BBIO earnings date and history (2026)
BridgeBio Pharma Inc. (BBIO) has no scheduled report date on the calendar yet. Its last report, on Thu Oct 29, came in at -$0.42 against a -$0.60 consensus; the stock moved +6.0% on the news. Not investment advice.
See every company reporting on the earnings calendar or the filed financial statements.
Past reports#
Data provided bySource: Twelve DataNewest first. The surprise is the reported EPS against the consensus going in, in percent; the move is the stock’s close-to-close change over the first session that could trade on the report, shown once that session has settled and only where the report’s timing is established — the earnings calendar, the time the company filed its earnings release with the SEC and the day’s trading volume, by majority.
| Date | Est | Actual | Move |
|---|---|---|---|
| Oct 29, 2026 | -$0.60 | -$0.42 | +6.0% |
| Aug 10, 2026 | -$0.64 | -$0.78 | -1.1% |
| May 7, 2026 | -$0.70 | -$0.84 | -0.1% |
| Feb 24, 2026 | -$0.75 | $1.00 | -2.6% |
| Oct 29, 2025 | -$0.88 | -$0.95 | — |
| Aug 5, 2025 | -$0.83 | -$0.95 | -8.9% |
| Apr 29, 2025 | $1.00 | -$0.88 | +5.3% |
| Feb 20, 2025 | -$1.09 | -$1.31 | +1.4% |
| Nov 12, 2024 | -$1.03 | -$0.86 | -5.7% |
| Aug 1, 2024 | -$1.09 | -$1.02 | +0.9% |
| May 2, 2024 | -$0.40 | -$0.05 | +2.6% |
| Feb 22, 2024 | -$0.95 | -$0.96 | -1.6% |
| Nov 2, 2023 | -$0.86 | -$1.08 | +1.0% |
| Aug 3, 2023 | -$0.86 | -$0.98 | +0.3% |
| May 4, 2023 | -$0.84 | -$0.92 | -6.3% |
| Feb 23, 2023 | -$0.86 | -$0.87 | -4.6% |
| Nov 3, 2022 | -$1.02 | -$0.93 | -0.2% |
| Aug 4, 2022 | -$0.92 | -$0.81 | +12.1% |
| May 5, 2022 | -$1.13 | -$1.19 | — |
| Feb 24, 2022 | -$0.83 | -$1.01 | +9.0% |
| Nov 4, 2021 | -$0.91 | -$1.06 | +2.9% |
| Aug 5, 2021 | -$0.93 | -$0.66 | — |
About this data#
Report dates, sessions, consensus EPS estimates, reported EPS and surprises are third-party figures, subject to change, and may not be accurate. A quarter whose session is known is shown with it; for one whose session is not, the move is left blank rather than guessed, because a pre-open and an after-close report trade on different sessions. The move is ChartRow's own: the first settled close that could trade on the report over the close before it, price return. Not investment advice.
FAQ#
- Did BBIO beat earnings last quarter?
- Yes: on Thu Oct 29 BBIO reported -$0.42 against a -$0.60 consensus, a +30.0% surprise.
- How did BBIO stock react to its last earnings?
- BBIO moved +6.0% on its last earnings report. It reported on Thu Oct 29, 2026, after the close, so the first trading session that could react was Fri Oct 30. BBIO closed at $70.73 on Thu Oct 29 and at $74.95 on Fri Oct 30, and $74.95 ÷ $70.73 − 1 = +6.0%. Both are ChartRow's own settled closing prices.
